文献速递主动脉疾病

高危患者使用开窗与分支腔内移植物修复胸腹主动脉瘤:不断演进但仍安全

Thoracoabdominal Aortic Aneurysm Repair Using Fenestrated and Branched Endovascular Grafts for High-Risk Patients: Evolving yet Safe.
PubMed 文献 · J Endovasc Ther · 2024-02-10

加拿大单中心回顾性分析2007年6月至2020年7月95例高危胸腹主动脉瘤患者行开窗或分支腔内修复(F/BEVAR),移植物部署成功率100%,院内死亡率9.5%,永久性截瘫4.2%,5年再干预累积概率46.3%,5年与8年生存率分别为50.1%与34.4%。

要点

  • 95例高危胸腹主动脉瘤患者行F/BEVAR,移植物部署成功率100%。
  • 院内死亡率9.5%,永久性截瘫4.2%,无患者需永久透析或气管切开。
  • 5年再干预累积概率46.3%,5年与8年生存率分别为50.1%与34.4%。

核心结论

  • 腔内胸腹主动脉瘤修复提供安全治疗选择,技术成功率高且肺部与肾脏并发症低,但高再干预率 reaffirm 需持续随访与进一步技术改进。

研究设计与样本

  • 加拿大单中心回顾性综述,纳入2007年6月至2020年7月所有使用F/BEVAR行腔内胸腹主动脉瘤修复的患者,共95例连续患者(63例男性,中位年龄74岁,四分位距70至78岁)。

主要发现

  • 移植物部署成功率100%,术中靶血管血运重建成功336/355(94.6%),腹腔干成功率最低为72/82(87.8%)。
  • 院内死亡率9.5%(择期7.4% vs 紧急/急诊21.4%,p=0.125),永久性截瘫4.2%(择期3.7% vs 紧急/急诊7.1%,p=0.458)。
  • 院内并发症包括卒中5.3%、急性心肌梗死8.4%、肠缺血5.3%,无患者需永久透析或气管切开。
  • 22例(23.2%)患者在住院期间因分支闭塞、内漏、重新对齐等指征需额外非计划手术。
  • 随访影像中43例(50%)患者发现至少1个内漏,靶血管通畅337/341(98.8%);5年再干预累积概率46.3%(95%CI 36.1-56.4),5年与8年生存率分别为50.1%(95%CI 38.4-65.4)与34.4%(95%CI 22.5-52.8)。

临床怎么用

  • 作者认为腔内胸腹主动脉瘤修复提供安全治疗选择,技术成功率高且肺部与肾脏并发症低。
  • 作者指出高再干预率 reaffirm 需持续患者随访与进一步技术改进。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose was to investigate outcomes of high-risk patients undergoing thoracoabdominal aortic aneurysm (TAAA) repair using fenestrated or branched endovascular aneurysm repair (F/BEVAR) devices at a single center in Canada. MATERIALS AND METHODS: A retrospective review of all patients undergoing endovascular TAAA repair with F/BEVAR from June 2007 to July 2020. Imaging and clinical endpoints of interest including death, reintervention, and target vessel patency were reported. RESULTS: Ninety-five consecutive patients underwent endovascular TAAA repair using F/BEVAR stent grafts (63 males, median age 74 [interquartile range 70, 78] years). Repairs included 81 elective and 14 urgent/emergent cases (6 ruptures and 8 symptomatic). Graft deployment was 100% successful. Intraoperative target vessel revascularization was successful in 336/355 (94.6%) vessels with the celiac having the lowest success rate 72/82 (87.8%). In-hospital mortality was 9.5% (7.4% elective and 21.4% urgent/emergent, p=0.125) and permanent paraplegia was 4.2% (3.7% elective and 7.1% urgent/emergent, p=0.458). In-hospital complications included stroke in 5.3%, acute myocardial infarction in 8.4%, and bowel ischemia in 5.3%. No patients required permanent dialysis or tracheostomy during their hospital stay. However, 22 (23.2%) patients required additional unplanned procedures for various indications (branch occlusion, endoleaks, realignment) during their hospital stay. Patients were followed up for a mean of 3.6 ± 3.0 years. Clinical follow-up was 100%, with 80/86 (93%) having surveillance imaging. On follow-up imaging, 43 (50%) patients had at least 1 endoleak identified and 337/341 (98.8%) of the target vessels were found to be patent. At 5 years, cumulative probability of reintervention was 46.3% (95% confidence interval [CI], 36.1-56.4). Survival at 5 and 8 years was 50.1% (95% CI, 38.4-65.4) and 34.4% (95% CI, 22.5-52.8), respectively. Progression of aneurysmal disease leading to rupture on follow-up was confirmed in 1 patient at 10 years. CONCLUSION: Endovascular TAAA repair provides a safe treatment option with a high technical success rate and low pulmonary and renal complications. Long-term survival is similar to previous literature; however, high rates of secondary reintervention reaffirm the need for ongoing patient follow-up and further technical improvements.Clinical ImpactThis study demonstrates that endovascular repair of TAAAs can be performed in a high-risk elderly population with acceptable rates of mortality, TALE and SCI, using evolving technology. The incidences of post-operative respiratory failure and renal dysfunction were lower in patients who underwent endovascular repair compared with open repair. Future technical and procedural refinements in addition to increasing surgical experience are expected to lead to further improvements in short- and long-term outcomes exceeding those of open repair.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Mahmood DN, Rocha R, Ouzounian M, et al. Thoracoabdominal Aortic Aneurysm Repair Using Fenestrated and Branched Endovascular Grafts for High-Risk Patients: Evolving yet Safe. J Endovasc Ther. 2024. PMID: 38339966. doi:10.1177/15266028241229005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。